NeuroWave Systems

NeuroWave Systems, founded in 2010 and headquartered in Beachwood, Ohio, is a commercial-stage medical device company focused on the neuroscience and anesthesia markets. The company has achieved FDA clearance for its NeuroSENSE Monitor, a unique bilateral EEG monitor that provides independent indices for each brain hemisphere to guide anesthesia delivery and detect asymmetry. NeuroWave is actively engaged in the clinical community, presenting at major anesthesiology conferences and pursuing a long-term vision of automated, closed-loop anesthesia systems. The company appears to be privately held and revenue-generating from the sale of its cleared medical device.

Advanced EEG signal processing and control engineering platform for bilateral brain function monitoring, enabling real-time indices for each brain hemisphere and targeting future closed-loop anesthesia delivery systems.

NeuroWave competes in the depth-of-anesthesia monitoring market against large, established players like Medtronic (BIS) and Masimo (SedLine). Its primary differentiation is bilateral, hemisphere-specific monitoring. Its long-term vision of automation would pit it against companies developing integrated OR systems and smart infusion pumps.